Better results for skin cancer surgery
Fluorescence imaging helps improve outcomes in head and neck skin cancer treatment – at reduced cost.
Mohs skin surgery can bring a permanent cure to skin cancers, when other methods have failed. Complete surgery and repair of the surgical site is normally a same day operation. However, Mohs is slow and extremely labor intensive because it depends on frozen sections processing to produce histological images. The cost and reduced throughput associated with frozen section processing limits its availability to patients while contributing to rising health care costs. University of Rochester professor Michael Giacomelli and his team want to solve this problem by using fluorescence microscopy.
Prof Giacomelli recently received NIH funding for his project named “Fluorescence microscopy for evaluation of Mohs surgical margins”. His research objective is to enable real-time evaluation of pathology in skin tissue with an order of magnitude reduction in processing time as compared to frozen sections.
The most common forms of cancer worldwide are basal cell carcinoma and squamous cell carcinoma. And their incidence is showing a rapidly increasing trend in the last years. Mohs surgery is a widely used technique for the treatment of nonmelanoma skin cancer that obtains extremely low recurrence rates by imaging tissue as it is removed from the body to ensure complete resection. Mohs micrographic surgery is a specialized technique to remove non-melanoma skin cancers.
Lasers enable clinical imaging of pathology in living human tissue
Giacomelli developed a way to image multiple depth slices without frozen section processing – by implementing two-photon imaging, widely used in the neurosciences to noninvasively image slices at different depths in living brains. The lab team’s research has adapted these fluorescence imaging technologies with rapid tissue labeling and image processing technologies. This enables real-time assessment of pathology in skin tissue. processing time compared to frozen sections has been reduced by an order of magnitude. The data collection time is further reduced using the lower-noised silicon photomultiplier detectors developed by Giacomelli’s group.
2-photon fluorescence microscopy can provide rapid point-of-care diagnosis of non-melanoma skin cancer through real-time imaging of fresh tissue biopsies.
The femtosecond laser system (a FemtoFiber ultra 920) chosen for the next iteration of the Giacomelli lab’s microscope is a possible solution for applications in nonlinear microscopy like two-photon excitation of fluorescent proteins and SHG based contrast mechanisms. With an emission wavelength of 920 nm, it provides the highest peak power for imaging with green and yellow fluorescent protein markers (GFP, YFP) commonly used in pathology, neurosciences and other laser-related biophotonic disciplines. Researchers appreciate the usability of the system since it is both, maintenance free and very compact.
Company
TOPTICA Photonics Inc.1120 Pittsford Victor Road
Pittsford, NY 14534
US
most read
Mitutoyo joins DMG Mori's DMQP program
At the DMG Mori in-house exhibition in Pfronten, Dr. Masahiko Mori, President and CEO of DMG Mori, and Shigeyuki Sasaki, President of Mitutoyo Corporation, sealed the partnership.
Stefan Schönegger becomes CTO at ABB Machine Automation
He has worked in various roles at Machine Automation since 2006 and has extensive experience in B&R technologies.
Heitec takes over Artschwager + Kohl
Through the acquisition, the company aims to expand its range of warehouse logistics solutions and open up new market segments.
Lapp Group takes over JJ-Lapp completely
JJ-Lapp will now become a wholly-owned subsidiary of the Group, with financial details remaining confidential.
Dr. Marc Lünnemann new CEO at Instrument Systems
Lünnemann took up the position on January 1, 2026 and brings with him over 20 years of international experience in the lighting, automotive and display industries.